Company
ChinaBrightGene Pharmaceutical Co., Ltd., Suzhou, China – FDA Inspections
Inspection records and compliance data for BrightGene Pharmaceutical Co., Ltd. in Suzhou. 4 FDA inspections on record, last inspected April 26, 2024.
Company Profile
This profile covers BrightGene Pharmaceutical Co., Ltd. based in Suzhou, China.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 3
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected March 14, 2013. Last inspected April 26, 2024.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 26, 2024 | VAI | Human Drugs · Drug Quality Assurance | 1240231 |
| December 8, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1038967 |
| September 10, 2015 | VAI | Human Drugs · Drug Quality Assurance | 942083 |
| March 14, 2013 | VAI | Human Drugs · Drug Quality Assurance | 831367 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
Tien (Tianjin) Pharmaceutical Co., Ltd.
Esteve Huayi Pharmaceutical Co., Ltd.
Suzhou Lixin Pharmaceutical Co. Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Qilu Pharmaceutical Co., Ltd. (Laoling Site)
Shandong Lixin Pharmaceutical Co., Ltd.
NANJING HAIRUN PHARMACEUTICAL CO., LTD.
Taiho Pharmaceutical Co., Ltd.
Company Information
Name
BrightGene Pharmaceutical Co., Ltd.
FEI Number
3009867839
Address
Suzhou Industrial Park, Floor C28, C27, C26, C25, No. 218 Xinghu Road; Linhuzhen Wuzhong, Suzhou, China
Country
China
ID: 532f1ca2-79a4-40bb-bf0e-3869fc8a2213